NPPES file of Aug 9, 2026

Matthew Gordon, MD

Pulmonary Disease Physician · Marlton, NJ

Matthew Gordon, MD is a pulmonary disease physician with a practice address in Marlton, New Jersey, and NPI 1922391952, issued on May 24, 2011. Check the license (New Jersey 25MA12275000, as entered in NPPES) on the New Jersey State Board of Medical Examiners; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1922391952
Name
Matthew Gordon
Credential
MD
Primary taxonomy
Pulmonary Disease Physician 207RP1001X
License numbers
25MA12275000 NJ
MD451992 PA
Self-reported in NPPES; status is on the state search
Practice location
Renaissance Square, 141 Route 70, Suite B, Marlton, NJ 08053
Phone
(856) 596-9057
Enumerated
May 24, 2011
Record last updated
Aug 26, 2024
Fax
(856) 596-9057
Medicare enrollment
Enrolled (PECOS I20240719001655); accepts Medicare assignment
Medical or professional school
Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc), 2011
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at Renaissance Square, 141 Route 70, Suite B

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Abhishek Agarwal, MDPulmonary Disease Physician1417365438
  2. Shanel McConner, NP-BCAcute Care Nurse Practitioner1760105746
  3. Christa McPhee, MDCritical Care Medicine (Internal Medicine) Physician1275039422
  4. Joseph Moran, D.O.Internal Medicine Physician1942734173
  5. Ali MustafaPulmonary Disease Physician1891226486
  6. Dana Supe, MDPulmonary Disease Physician1679511208

Verify Matthew Gordon in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersNew Jersey State Board of Medical Examiners
    Search for license 25MA12275000
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the New Jersey license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

45% fewer Medicare Part D claims than the average pulmonary disease physician in 2024

789 Medicare Part D claims for 138 beneficiaries, against an average of 1,425 among the 11,596 providers of this specialty who prescribed in Part D. Brand-name drugs were 52% of claims.

  1. Matthew Gordon789
  2. Specialty average1,425

Most prescribed

  1. Albuterol Sulfate Hfa86 claims
  2. Anoro Ellipta57 claims
  3. Azithromycin57 claims
  4. Trelegy Ellipta57 claims
  5. Montelukast Sodium50 claims
  6. Spiriva Respimat41 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 76.7 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score55.2
  2. Costout of 100 · 30%54.9
  3. Promoting interoperabilityout of 100 · 25%98.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $3,520.24

13 payments; by number, the most common kind was food and beverage; the largest payer was Csl Behring. The 8,806 providers of this specialty with any payment received $5,159.88 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Matthew Gordon$3,520.24
  2. Specialty average$5,159.88

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Virtua Medical Group, PAMarlton, NJ

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Matthew Gordon among 509 pulmonary disease physician records in New Jersey

Matthew Gordon, MD is one of 509 pulmonary disease physician records with a practice address in New Jersey. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2011, is newer than 75% of them.

  • NPI issued2011 · 75% of these records are older, 21% newer
  • In a Medicare fileYes · 87% of these records are
  • In the CMS Doctors and Clinicians fileYes · 79% of these records are
  • Graduated2011 · median 1998 among the 401 with a school on file
  • Record last updated2024 · 55% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RP1001X and a New Jersey practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Pulmonary Disease Physician providers in New Jersey

There are 509 pulmonary disease physician records in New Jersey.

The 8 pulmonary disease physician records with the nearest ZIP codes

  1. Abhishek Agarwal, MDMarlton, NJ 080531417365438
  2. Donald Auerbach, M.DMarlton, NJ 080531225036866
  3. John Bermingham, DOMarlton, NJ 080531700847910
  4. Heather Giannini, M.D.Marlton, NJ 080531447646310
  5. Patrick Mulhall, M.D.Marlton, NJ 080531982997482
  6. Thomas Nugent, M.D.Marlton, NJ 080531457321044
  7. Lukasz Polisiakiewicz, D.O.Marlton, NJ 080531295033819
  8. Allen Salm, MDMarlton, NJ 080531710977392

Common questions

What is Matthew Gordon, MD's NPI number?

Matthew Gordon, MD's National Provider Identifier (NPI) is 1922391952, issued on May 24, 2011. An NPI identifies a provider in billing; it is not a license.

Where is Matthew Gordon, MD located?

The NPPES record lists a practice address at Renaissance Square, 141 Route 70, Suite B, Marlton, NJ, 08053. Phone: (856) 596-9057. Providers update this record themselves, so call before visiting.

How can I verify Matthew Gordon, MD's license?

NPPES lists New Jersey license number 25MA12275000, as entered by the provider. Search the New Jersey State Board of Medical Examiners at https://newjersey.mylicense.com/verification/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Matthew Gordon, MD prescribe under Medicare Part D?

In 2024, Matthew Gordon, MD had 789 Medicare Part D claims for 138 beneficiaries; the average among pulmonary disease physician prescribers was 1,425. Part D covers Medicare prescriptions only.

What is Matthew Gordon, MD's MIPS final score?

The 2023 MIPS final score is 76.7 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.